Cancer
Credibility 80
Ormeloxifene, a non-steroidal selective estrogen receptor modulator induces senescence in breast cancer cells.
October 1, 2026 · Molecular biology reports
Key takeaway
This study found a medicine called Ormeloxifene helps stop breast cancer cells from growing, making them "age" and stop dividing. This matters because it could lead to new ways to treat breast cancer, especially for those cases that are harder to manage.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read